Jiangxi Synergy Pharmaceutical (300636.SZ): The raw material drug of Telmisartan Potassium has been approved by the China Food and Drug Administration (CDE).

Jiangxi Synergy Pharmaceutical (300636.SZ) announced that the company recently obtained the approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration. The company's submission for the raw material of "Valsartan Potassium" has been approved by the CDE. Valsartan Potassium is used for the treatment of primary hypertension in adults.